MediWound Ltd (MDWD)
19.01
+0.11
(+0.58%)
USD |
NASDAQ |
May 07, 16:00
19.01
0.00 (0.00%)
After-Hours: 16:58
MediWound Revenue (Quarterly): 5.338M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.338M |
| September 30, 2023 | 4.776M |
| June 30, 2023 | 4.773M |
| March 31, 2023 | 3.799M |
| December 31, 2022 | 11.62M |
| September 30, 2022 | 5.803M |
| June 30, 2022 | 4.668M |
| March 31, 2022 | 4.407M |
| December 31, 2021 | 5.487M |
| September 30, 2021 | 6.372M |
| June 30, 2021 | 6.057M |
| March 31, 2021 | 5.847M |
| December 31, 2020 | 6.673M |
| September 30, 2020 | 6.625M |
| June 30, 2020 | 4.027M |
| March 31, 2020 | 4.438M |
| December 31, 2019 | 5.442M |
| September 30, 2019 | 5.14M |
| June 30, 2019 | 20.75M |
| March 31, 2019 | 0.461M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.992M |
| September 30, 2018 | 0.858M |
| June 30, 2018 | 1.031M |
| March 31, 2018 | 0.52M |
| December 31, 2017 | 0.53M |
| September 30, 2017 | 0.739M |
| June 30, 2017 | 0.687M |
| March 31, 2017 | 0.54M |
| December 31, 2016 | 0.43M |
| September 30, 2016 | 0.518M |
| June 30, 2016 | 0.356M |
| March 31, 2016 | 0.254M |
| December 31, 2015 | 0.267M |
| September 30, 2015 | 0.102M |
| June 30, 2015 | 0.165M |
| March 31, 2015 | 0.067M |
| December 31, 2014 | 0.124M |
| September 30, 2014 | 0.046M |
| June 30, 2014 | 0.039M |
| March 31, 2014 | 0.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.799M
Minimum
Mar 2023
20.75M
Maximum
Jun 2019
6.423M
Average
5.442M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Compugen Ltd | 33.46M |
| Pluri Inc | 0.105M |
| BioLine Rx Ltd | 4.80M |
| Can Fite Biofarma Ltd | 0.155M |
| BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.743M |
| Total Expenses (Quarterly) | 9.443M |
| EPS Diluted (Quarterly) | -0.19 |
| Enterprise Value | 137.85M |
| Gross Profit Margin (Quarterly) | 13.47% |
| Profit Margin (Quarterly) | -32.65% |
| Earnings Yield | -4.05% |
| Normalized Earnings Yield | -4.051 |